Back
NovoCure Vs. Las Vegas Sands Industry Stock Comparison
Sell
43
NVCR
NovoCure
Last Price:
14.18
Seasonality Move:
6.82%
Sell
50
LVS
Las Vegas Sands
Last Price:
46.66
Seasonality Move:
-2.9%
Sell
43
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $12.74. The Score for NVCR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Las Vegas Sands (LVS)
is a Sell
Is Las Vegas Sands a Buy, Sell or Hold?
- The current Las Vegas Sands [LVS] share price is $44.54. The Score for LVS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- LVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
LVS Stock Price Chart
What is Las Vegas Sands's stock price today?
-
The Las Vegas Sands share price today is $44.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LVS is experiencing slight selling pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 45.65 | Sell |
| Chaikin Money Flow: | -25256 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.19 - 14.55) | Sell |
| Bollinger Bands (100): | (12.9 - 15.44) | Sell |
LVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.86 | Sell |
| Relative Strength Index (14 RSI): | 27.94 | Sell |
| Chaikin Money Flow: | -577281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.1 - 52.64) | Sell |
| Bollinger Bands (100): | (47.81 - 52.97) | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.36 | Buy |
| 20-day SMA: | 12.98 | Sell |
| 50-day SMA: | 14.23 | Sell |
| 200-day SMA: | 17.26 | Sell |
| 8-day EMA: | 12.52 | Buy |
| 20-day EMA: | 12.92 | Sell |
| 50-day EMA: | 13.7 | Sell |
| 200-day EMA: | 22.33 | Sell |
LVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.51 | Sell |
| 20-day SMA: | 48.55 | Sell |
| 50-day SMA: | 50.68 | Sell |
| 200-day SMA: | 50.36 | Sell |
| 8-day EMA: | 45.66 | Sell |
| 20-day EMA: | 47.65 | Sell |
| 50-day EMA: | 49.54 | Sell |
| 200-day EMA: | 50.54 | Sell |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.
Las Vegas Sands Earnings Growth & LVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.08 per share, an increase this year of $0.84 per share, and an increase next year of $0.39 per share.
NovoCure Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Las Vegas Sands Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||